Cerebrolysin
Peptide therapy: benefits, side effects, cost and protocols
Cerebrolysin is a mixture of enzymatically-treated peptides derived from pig brain containing brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and ciliary neurotrophic factor (CNTF). It is used as a therapy for brain diseases in dozens of countries across Eurasia.
Sources: FDA / PubMed / ClinicalTrials.gov View
Spec sheet
- FDA status
- Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
- Evidence
- Strong Evidence
Who it's for
Who Cerebrolysin is usually considered for
- Cognitive support
- Brain recovery
- Neuroprotection
- Memory research
Mechanism
How Cerebrolysin works
Contains neurotrophic factors that may support neuronal survival, synaptic plasticity, and neurogenesis.
Evidence
Key studies
677 papers on PubMed
- 01
[Effects of simultaneous use of Cerebrolysin and alteplase on hemorrhagic transformation of brain infarction and functional outcome in stroke patients: CEREHETIS, a randomized, multicenter pilot trial]
Zh Nevrol Psikhiatr Im S S Korsakova / Zh Nevrol Psikhiatr Im S S Korsakova / RCT
14 days treatment, 90 days follow-up
- 02
Cerebrolysin with alteplase reduced symptomatic hemorrhagic transformation but showed no functional benefit at 90 days
- 03
[Cerebrolysin and the optimal timing of anticoagulation resumption in stroke: combined post hoc survival analysis of the CEREHETIS trial]
Zh Nevrol Psikhiatr Im S S Korsakova / Zh Nevrol Psikhiatr Im S S Korsakova / Phase 3
Cerebrolysin reduced hemorrhagic transformation risk and enabled earlier anticoagulation resumption in stroke.
- 04
Cerebrolysin reduced hemorrhagic transformation risk and enabled earlier anticoagulation resumption in stroke
- 05
Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin
- 06
Alvarez XA, Cacabelos R, Sampedro C et al
Eur J Neurol / Phase 2
Cerebrolysin at all three dosages improved global clinical function and cognition in moderate to moderately severe Alzheimer's disease.
- 07
Cerebrolysin at all three dosages improved global clinical function and cognition in moderate to moderately severe Alzheimer's disease
- 08
Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
- 09
Muresanu DF, Heiss WD, Hoemberg V et al
Stroke / Phase 3
- 10
Cerebrolysin significantly improved motor function in upper extremities at day 90 post-stroke vs placebo
FAQ
Cerebrolysin questions
What is CEREBROLYSIN?
Cerebrolysin is a mixture of peptides and amino acids derived from pig brain tissue, researched extensively for neurotrophic and neuroprotective effects, particularly in cognitive recovery.
How does CEREBROLYSIN work?
Contains neurotrophic factors that may support neuronal survival, synaptic plasticity, and neurogenesis.
Is CEREBROLYSIN legal to buy?
CEREBROLYSIN is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy CEREBROLYSIN?
CEREBROLYSIN has mixed availability - it can be found through both compounding pharmacies (with prescription) and research suppliers.
What category does CEREBROLYSIN belong to?
CEREBROLYSIN is primarily classified as a cognitive enhancement peptide. Nootropic peptides researched for cognitive function, memory, focus, neuroprotection, and neurogenesis.
What are the research benefits of CEREBROLYSIN?
CEREBROLYSIN has been studied for: Cognitive support, Brain recovery, Neuroprotection, Memory research. Neurotrophic factors; brain recovery research.
News
Cerebrolysin in the news
Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study - American Heart Association Journals
American Heart Association Journals / 21 months ago
Cerebrolysin: Positive Cognitive Effect in Vascular Dementia - Medscape
Medscape / 167 months ago
Neuroprotection by Cerebrolysin and Citicoline Through the Upregulation of Brain-Derived Neurotrophic Factor (BDNF) Expression in the Affected Neural Cells: A Preliminary Clue Obtained Through an In Vitro Study - Cureus
Cureus / 33 months ago
Comparing Cervical Myelopathy With Injection Cerebrolysin Vs. Placebo in DCM - Physicians Weekly
Physicians Weekly / 46 months ago
Cerebrolysin®: a guide to its use in dementia - Springer Nature Link
Springer Nature Link / 173 months ago
News aggregated via Google News. Inclusion does not imply endorsement.
Considering Cerebrolysin?
The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.